Category: Articles
How the USPTO’s AI Inventorship Reset Changes Patent Portfolio Strategy for Companies Building with Generative AI
Ex Parte Injunctions in Patent Cases: What the Courts’ Cautious New Standard Means for Product Launches
Switzerland Is Revising Its Patent Act: What the Incoming Reforms Mean for Patent Landscape Strategy
When Your Competitor Files the Same Invalidity Arguments Twice: How to Build a Prior Art Case That Holds Up Under Repeat Attack
The UPC’s First FRAND Decision: What the Dolby v. Beko Ruling Means for SEP Licensing Negotiations
The Swiss Federal Patent Court’s Expedited Nullity Proceedings: What It Means for Pharma and MedTech IP Portfolios
The Rise of NPE Litigation: Why Non-Practicing Entities Are Targeting Mid-Market Companies — and How Proactive Infringement Monitoring Changes Your Defence
Why This Is Now One of the Most Valuable Patent Licensing Markets in the World — and How to Build a Strategy for It
